BJP Try Advances in Psychiatric Treatment Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


The British Journal of Psychiatry (2006) 189: 156-160. doi: 10.1192/bjp.bp.105.017434
© 2006 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colman, I.
Right arrow Articles by Jones, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colman, I.
Right arrow Articles by Jones, P. B.

Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort

Ian Colman, MSc

Department of Psychiatry, University of Cambridge, Cambridge

Michael E. J. Wadsworth, PhD

Medical Research Council National Survey of Health and Development, Department of Epidemiology and Public Health, University College London Medical School, London

Tim J. Croudace, PhD and Peter B. Jones, PhD

Department of Psychiatry, University of Cambridge, Cambridge, UK

Correspondence: Professor Peter B. Jones, Department of Psychiatry, Box 189, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Tel: +44(0)1223 336 961; fax: +44(0)1223 336968; e-mail: pbj21{at}cam.ac.uk

Declaration of interest None.

Funding detailed in Acknowledgements.

Background Psychotropic medication use is common and increasing. Use of such drugs at the individuallevel over long periods has not been reported.

Aims To describe antidepressant, anxiolytic and hypnotic drug use, and associations between such medication use and common mental disorder, over a 22-year period.

Method Questions about psychotropic medication use and symptoms of common mental disorder were asked of more than 3000 members of the 1946 British birth cohort at multiple time points between ages 31 and 53 years.

Results Prevalence of any antidepressant, anxiolytic or hypnotic use increased significantly from 1977 (30.6 per 1000) to 1999 (59.1 per 1000) as the cohort aged. Less than 30% with mental disorder used antidepressants, anxiolytics or hypnotics. Previous use of antidepressant, anxiolytic or hypnotic was a strong predictor of future use during an episode of mental disorder (odds ratios 3.0-8.4); this association became weaker over time.

Conclusions Pharmacotherapy is infrequently used by individuals with common mental disorder in Britain; this has not changed in the past three decades.


Related articles in BJP:

From the Editor's desk
Peter Tyrer
BJP 2006 189: 200. [Full Text]  

Highlights of this issue
Kimberlie Dean
BJP 2006 189: A5. [Full Text]  



This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
I. Colman, T. J. Croudace, M. E. J. Wadsworth, D. Kuh, and P. B. Jones
Psychiatric outcomes 10 years after treatment with antidepressants or anxiolytics
The British Journal of Psychiatry, October 1, 2008; 193(4): 327 - 331.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
P. Tyrer
From the Editor's desk
The British Journal of Psychiatry, May 1, 2008; 192(5): 400 - 400.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2006 The Royal College of Psychiatrists.